INO logo

Inovio Pharmaceuticals (INO) Total Assets

Annual Total Assets

$170.95 M
-$177.58 M-50.95%

31 December 2023

INO Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$107.06 M
-$26.74 M-19.98%

30 September 2024

INO Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

INO Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-51.0%-44.6%
3 y3 years-68.3%-80.0%
5 y5 years+30.4%-29.4%

INO Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-68.3%at low-80.0%at low
5 y5 years-68.3%+30.4%-83.7%at low
alltimeall time-68.3%+3054.6%-83.7%+2830.7%

Inovio Pharmaceuticals Total Assets History

DateAnnualQuarterly
Sept 2024
-
$107.06 M(-20.0%)
June 2024
-
$133.80 M(+3.6%)
Mar 2024
-
$129.11 M(-24.5%)
Dec 2023
$170.95 M(-51.0%)
$170.95 M(-11.5%)
Sept 2023
-
$193.10 M(-17.1%)
June 2023
-
$233.04 M(-12.6%)
Mar 2023
-
$266.58 M(-23.5%)
Dec 2022
$348.53 M(-29.7%)
$348.53 M(-11.1%)
Sept 2022
-
$391.97 M(-14.7%)
June 2022
-
$459.40 M(+3.1%)
Mar 2022
-
$445.51 M(-10.2%)
Dec 2021
$495.94 M(-8.1%)
$495.94 M(-7.4%)
Sept 2021
-
$535.76 M(-9.5%)
June 2021
-
$591.84 M(-9.6%)
Mar 2021
-
$654.86 M(+21.3%)
Dec 2020
$539.77 M(+275.0%)
$539.77 M(+23.3%)
Sept 2020
-
$437.81 M(-1.2%)
June 2020
-
$443.19 M(+30.8%)
Mar 2020
-
$338.92 M(+135.4%)
Dec 2019
$143.95 M(+9.8%)
$143.95 M(-5.0%)
Sept 2019
-
$151.53 M(-8.2%)
June 2019
-
$165.07 M(-13.6%)
Mar 2019
-
$191.17 M(+45.8%)
Dec 2018
$131.11 M(-30.0%)
$131.11 M(-6.8%)
Sept 2018
-
$140.70 M(-5.5%)
June 2018
-
$148.92 M(-14.2%)
Mar 2018
-
$173.66 M(-7.2%)
Dec 2017
$187.24 M(+7.8%)
$187.24 M(-8.1%)
Sept 2017
-
$203.68 M(+28.2%)
June 2017
-
$158.85 M(+3.6%)
Mar 2017
-
$153.31 M(-11.7%)
Dec 2016
$173.71 M(-18.8%)
$173.71 M(-10.7%)
Sept 2016
-
$194.55 M(-4.6%)
June 2016
-
$203.99 M(-3.5%)
Mar 2016
-
$211.29 M(-1.2%)
Dec 2015
$213.84 M(+62.3%)
$213.84 M(-7.3%)
Sept 2015
-
$230.77 M(+14.4%)
June 2015
-
$201.70 M(+71.1%)
Mar 2015
-
$117.86 M(-10.6%)
Dec 2014
$131.79 M(+49.3%)
$131.79 M(-2.0%)
Sept 2014
-
$134.53 M(-5.4%)
June 2014
-
$142.15 M(-6.3%)
Mar 2014
-
$151.66 M(+71.8%)
Dec 2013
$88.29 M(+95.6%)
$88.29 M(+0.3%)
Sept 2013
-
$88.02 M(+72.6%)
June 2013
-
$50.99 M(-12.4%)
Mar 2013
-
$58.20 M(+28.9%)
Dec 2012
$45.14 M(-26.1%)
$45.14 M(+1.5%)
Sept 2012
-
$44.48 M(-8.5%)
June 2012
-
$48.60 M(-12.2%)
Mar 2012
-
$55.35 M(-9.4%)
Dec 2011
$61.11 M
$61.11 M(-3.4%)
DateAnnualQuarterly
Sept 2011
-
$63.27 M(-6.8%)
June 2011
-
$67.86 M(-9.3%)
Mar 2011
-
$74.85 M(+33.5%)
Dec 2010
$56.07 M(-30.5%)
$56.07 M(-5.5%)
Sept 2010
-
$59.32 M(-1.6%)
June 2010
-
$60.28 M(-24.4%)
Mar 2010
-
$79.72 M(-1.1%)
Dec 2009
$80.63 M(+106.8%)
$80.63 M(-10.8%)
Sept 2009
-
$90.44 M(+42.9%)
June 2009
-
$63.27 M(+75.8%)
Mar 2009
-
$35.98 M(-7.7%)
Dec 2008
$38.99 M(-2.0%)
$38.99 M(+27.9%)
Sept 2008
-
$30.48 M(-5.5%)
June 2008
-
$32.26 M(-9.7%)
Mar 2008
-
$35.72 M(-10.2%)
Dec 2007
$39.77 M(+10.6%)
$39.77 M(-2.7%)
Sept 2007
-
$40.87 M(-7.9%)
June 2007
-
$44.35 M(+39.0%)
Mar 2007
-
$31.92 M(-11.2%)
Dec 2006
$35.95 M(+24.1%)
$35.95 M(+80.6%)
Sept 2006
-
$19.90 M(-13.6%)
June 2006
-
$23.03 M(-11.4%)
Mar 2006
-
$25.98 M(-10.4%)
Dec 2005
$28.98 M(+38.3%)
$28.98 M(+82.1%)
Sept 2005
-
$15.92 M(-21.0%)
June 2005
-
$20.15 M(-11.9%)
Mar 2005
-
$22.88 M(+9.2%)
Dec 2004
$20.95 M(+29.1%)
$20.95 M(-7.4%)
Sept 2004
-
$22.63 M(-8.3%)
June 2004
-
$24.68 M(+57.3%)
Mar 2004
-
$15.68 M(-3.4%)
Dec 2003
$16.23 M(+199.5%)
$16.23 M(+63.1%)
Sept 2003
-
$9.95 M(+172.5%)
June 2003
-
$3.65 M(-26.6%)
Mar 2003
-
$4.98 M(-8.1%)
Dec 2002
$5.42 M(-18.3%)
$5.42 M(-17.3%)
Sept 2002
-
$6.55 M(-16.9%)
June 2002
-
$7.88 M(+49.9%)
Mar 2002
-
$5.26 M(-25.6%)
Dec 2001
$6.63 M(-42.2%)
-
Sept 2001
-
$7.06 M(-20.7%)
June 2001
-
$8.91 M(-22.5%)
Mar 2001
-
$11.49 M(+25.1%)
Mar 2001
$11.49 M(-18.0%)
-
Dec 2000
-
$9.18 M(-16.6%)
Sept 2000
-
$11.01 M(-13.4%)
June 2000
-
$12.71 M(-9.3%)
Mar 2000
$14.01 M(+42.9%)
$14.01 M(-7.8%)
Dec 1999
-
$15.20 M(-8.4%)
Sept 1999
-
$16.60 M(-8.8%)
June 1999
-
$18.20 M(+85.6%)
Mar 1999
$9.81 M
$9.81 M(-18.9%)
Dec 1998
-
$12.10 M

FAQ

  • What is Inovio Pharmaceuticals annual total assets?
  • What is the all time high annual total assets for Inovio Pharmaceuticals?
  • What is Inovio Pharmaceuticals annual total assets year-on-year change?
  • What is Inovio Pharmaceuticals quarterly total assets?
  • What is the all time high quarterly total assets for Inovio Pharmaceuticals?
  • What is Inovio Pharmaceuticals quarterly total assets year-on-year change?

What is Inovio Pharmaceuticals annual total assets?

The current annual total assets of INO is $170.95 M

What is the all time high annual total assets for Inovio Pharmaceuticals?

Inovio Pharmaceuticals all-time high annual total assets is $539.77 M

What is Inovio Pharmaceuticals annual total assets year-on-year change?

Over the past year, INO annual total assets has changed by -$177.58 M (-50.95%)

What is Inovio Pharmaceuticals quarterly total assets?

The current quarterly total assets of INO is $107.06 M

What is the all time high quarterly total assets for Inovio Pharmaceuticals?

Inovio Pharmaceuticals all-time high quarterly total assets is $654.86 M

What is Inovio Pharmaceuticals quarterly total assets year-on-year change?

Over the past year, INO quarterly total assets has changed by -$86.04 M (-44.56%)